Volume reduction surgery for end-stage ischemic heart disease

Area of Science:

• Cardiology
• Cardiac Surgery
• Medical Imaging

Background:

• End-stage ischemic heart failure presents a significant clinical challenge.
• The Dor procedure (infarction excision surgery) is a surgical option for these patients.
• Echocardiography is crucial for assessing cardiac function and surgical outcomes.

Purpose of the Study:

• To evaluate the efficacy and outcomes of the Dor procedure for end-stage ischemic heart failure.
• To highlight the role of echocardiography in assessing surgical results.
• To emphasize the importance of surgeon-echocardiographer collaboration.

Main Methods:

• Analysis of a multicenter study involving 439 patients undergoing the Dor procedure.
• Utilizing echocardiography, including intraoperative transesophageal echocardiography, for cardiac assessment.
• Reviewing preoperative mortality and 18-month survival rates.

Main Results:

• Average ejection fraction increased from 29% to 39% post-surgery.
• Overall 18-month survival rate was 89%.
• Preoperative mortality rate was 6.6%.

Conclusions:

• The Dor procedure is a valuable surgical treatment for end-stage ischemic heart failure.
• Echocardiography, particularly 3D echocardiography, is essential for evaluating surgical success.
• Effective communication between cardiac surgeons and echocardiographers is vital for optimal patient outcomes.